Physician profile
Daniel L Bangart
NPI 1447220678
$3,620.61
in general payments reported to CMS, 2019-2025
20 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $1,529 · 2021: $327 · 2022: $630 · 2023: $332 · 2024: $181 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $1,409.17 | 2019-2022 | |
| Stryker Corporation | $551.16 | 2020-2025 | 7 X 23mm Citrelock Implant, Valor, Ortholoc 2 Lapifuse |
| Djo, LLC | $352.43 | 2019-2024 | Cmf |
| Nevro Corp. | $282.79 | 2022-2024 | Senza |
| Orthofix Medical, INC. | $151.87 | 2022-2025 | Physio-Stim, Spinal-Stim |
| Integra Lifesciences Corporation | $135.81 | 2020-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $131.79 | 2019-2022 | |
| Wright Medical Technology, INC. | $93.08 | 2019-2020 | |
| Melinta Therapeutics, LLC | $83.35 | 2019-2022 | |
| Abbvie INC. | $79.34 | 2025 | |
| Depuy Synthes Sales INC. | $78.83 | 2019 | |
| Amgen INC. | $70.10 | 2024-2025 | Krystexxa |
| Organogenesis INC. | $44.96 | 2021 | |
| Treace Medical Concepts, INC. | $39.62 | 2022 | |
| Flower Orthopedics Coporation | $36.36 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $20.65 | 2024 | Nalu Neurostimulation System |
| Horizon Therapeutics Plc | $19.08 | 2021 | |
| Osiris Therapeutics INC. | $13.97 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.54 | 2025 | Jublia |
| Biotissue Holdings INC. | $12.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Bangart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.